Goldman Capital Management’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$235K Sell
9,200
-7,700
-46% -$199K 0.23% 23
2017
Q3
$474K Sell
16,900
-2,400
-12% -$66.9K 0.45% 19
2017
Q2
$579K Sell
19,300
-13,538
-41% -$383K 0.61% 20
2017
Q1
$979K Sell
32,838
-19,600
-37% -$613K 0.94% 17
2016
Q4
$1.81M Sell
52,438
-29,200
-36% -$1.01M 1.57% 10
2016
Q3
$5.4M Sell
81,638
-1,500
-2% -$93.4K 4.34% 8
2016
Q2
$4.71M Buy
83,138
+3,800
+5% +$214K 4.06% 9
2016
Q1
$4.63M Buy
79,338
+1,746
+2% +$92.7K 3.5% 8
2015
Q4
$4.56M Buy
77,592
+7,400
+11% +$437K 3.54% 8
2015
Q3
$4.01M Buy
70,192
+17,054
+32% +$1.37M 2.87% 9
2015
Q2
$4.8M Sell
53,138
-8,800
-14% -$762K 2.99% 9
2015
Q1
$5.96M Hold
61,938
3.48% 8
2014
Q4
$5.42M Buy
61,938
+79
+0.1% +$6.81K 3% 8
2014
Q3
$5.65M Buy
61,859
+921
+2% +$99.7K 2.83% 10
2014
Q2
$7.02M Hold
60,938
3.48% 7
2014
Q1
$7.47M Sell
60,938
-1,462
-2% -$192K 4.04% 6
2013
Q4
$5.83M Hold
62,400
3.18% 10
2013
Q3
$6.79M Sell
62,400
-6,200
-9% -$604K 4.48% 7
2013
Q2
$5.78M Buy
+68,600
New +$5.69M 3.3% 8

Other funds holding TRIB